Perennial Advisors, LLC Glycomimetics Inc Transaction History

Perennial Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$1.8 - $2.39 $1,764 - $2,342	-980 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$2.89 - $4.22 $57 - $84	-20 Reduced 2.0%	980 $3,000
Q4 2020 Feb 12, 2021	BUY	$2.69 - $4.24 $2,690 - $4,240	1,000 New	1,000 $4,000
Q3 2020 Nov 16, 2020	SELL	$3.07 - $5.0 $3,070 - $5,000	-1,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.06 - $3.76 $1,030 - $1,880	-500 Reduced 33.33%	1,000 $4,000
Q1 2020 May 19, 2020	BUY	$1.83 - $5.41 $2,745 - $8,115	1,500 New	1,500 $9,000
Q1 2019 Apr 30, 2019	SELL	$9.96 - $13.44 $9,960 - $13,440	-1,000 Closed	0 $0
Q4 2017 Jan 29, 2018	SELL	$10.51 - $17.22 $5,255 - $8,610	-500 Reduced 33.33%	1,000 $17,000
Q3 2017 Oct 30, 2017	BUY	$10.14 - $14.85 $15,210 - $22,275	1,500	1,500 $21,000

17.7M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $13.1M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Perennial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Perennial Advisors, LLC with notifications on news.